Tevogen Bio Holdings Inc.

NASDAQ (USD): Tevogen Bio Holdings Inc. (TVGN)

Last Price

1.52

Today's Change

+0.48 (46.15%)

Day's Change

1.38 - 2.47

Trading Volume

206,001,303

Overview

Market Cap

259 Million

Shares Outstanding

170 Million

Avg Volume

6,023,760

Avg Price (50 Days)

0.52

Avg Price (200 Days)

2.92

PE Ratio

25.33

EPS

0.06

Earnings Announcement

27-May-2024

Previous Close

1.04

Open

1.49

Day's Range

1.38 - 2.47

Year Range

0.256 - 21.09

Trading Volume

206,024,308

Price Change Highlight

1 Day Change

46.15%

5 Day Change

406.67%

1 Month Change

237.63%

3 Month Change

108.25%

6 Month Change

-33.62%

Ytd Change

-86.33%

1 Year Change

-85.99%

3 Year Change

-84.71%

5 Year Change

-84.71%

10 Year Change

-84.71%

Max Change

-84.71%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment